Tumor infiltrating immune cells (TIICs) as a biomarker for prognosis benefits in patients with osteosarcoma

BACKGROUND: Osteosarcoma is a rare malignant bone tumor in adolescents and children. Poor prognosis has always been a difficult problem for patients with osteosarcoma. Recent studies have shown that tumor infiltrating immune cells (TIICs) are associated with the clinical outcome of osteosarcoma pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ying, Zhao, Bo, Wang, Xiaohu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579940/
https://www.ncbi.nlm.nih.gov/pubmed/33087099
http://dx.doi.org/10.1186/s12885-020-07536-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579940/
https://www.ncbi.nlm.nih.gov/pubmed/33087099
http://dx.doi.org/10.1186/s12885-020-07536-3

Ejemplares similares